Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand
We recently demonstrated that SB269652 (1) engages one protomer of a dopamine D2 receptor (D2R) dimer in a bitopic mode to allosterically inhibit the binding of dopamine at the other protomer. Herein, we investigate structural deter- minants for allostery, focusing on modifications to three moieties...
| Main Authors: | Mistry, Shailesh N., Shonberg, Jeremy, Draper-Joyce, Christopher J., Klein Herenbrink, Carmen, Michino, Mayako, Shi, Lei, Christopoulos, Arthur, Capuano, Ben, Scammells, Peter J., Lane, J. Robert |
|---|---|
| Format: | Article |
| Published: |
American Chemical Society
2015
|
| Online Access: | https://eprints.nottingham.ac.uk/30315/ |
Similar Items
Structure–activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptor
by: Shonberg, Jeremy, et al.
Published: (2015)
by: Shonberg, Jeremy, et al.
Published: (2015)
Novel fused arylpyrimidinone based allosteric modulators of the M1 muscarinic acetylcholine receptor
by: Mistry, Shailesh N., et al.
Published: (2016)
by: Mistry, Shailesh N., et al.
Published: (2016)
A thieno[2,3-d]pyrimidine scaffold is a novel negative allosteric modulator of the dopamine D2 receptor
by: Fyfe, Tim J., et al.
Published: (2018)
by: Fyfe, Tim J., et al.
Published: (2018)
Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor
by: Mistry, Shailesh N., et al.
Published: (2013)
by: Mistry, Shailesh N., et al.
Published: (2013)
4-Phenylpyridin-2-one derivatives: a novel class of positive allosteric modulator of the M1 muscarinic acetylcholine receptor
by: Mistry, Shailesh N., et al.
Published: (2015)
by: Mistry, Shailesh N., et al.
Published: (2015)
Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor
by: Abdul-Ridha, Alaa, et al.
Published: (2014)
by: Abdul-Ridha, Alaa, et al.
Published: (2014)
Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics
by: Cook, A.E., et al.
Published: (2014)
by: Cook, A.E., et al.
Published: (2014)
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor
by: Abdul-Ridha, Alaa, et al.
Published: (2014)
by: Abdul-Ridha, Alaa, et al.
Published: (2014)
Assessment of the molecular mechanisms of action of novel 4-phenylpyridine-2-one and 6-phenylpyrimidin-4-one allosteric modulators at the M1 muscarinic acetylcholine receptors
by: van der Westhuizen, Emma T., et al.
Published: (2018)
by: van der Westhuizen, Emma T., et al.
Published: (2018)
The role of kinetic context in apparent biased
agonism at GPCRs
by: Klein Herenbrink, Carmen, et al.
Published: (2016)
by: Klein Herenbrink, Carmen, et al.
Published: (2016)
Positive allosteric modulation of the muscarinic M1 receptor improves efficacy of antipsychotics in mouse glutamatergic deficit models of behavior
by: Choy, Kwok H.C., et al.
Published: (2016)
by: Choy, Kwok H.C., et al.
Published: (2016)
Medicinal Chemistry & Chemical Biology Approaches to Investigate Prospective Treatments for CNS Diseases: Dopamine D1 Receptor Positive Allosteric Modulators, Dopamine D2 Receptor Positive & Negative Allosteric Modulators, Dopamine D2 Receptor-Ligand Kinetics
by: Fyfe, Tim
Published: (2019)
by: Fyfe, Tim
Published: (2019)
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
by: Sykes, David A., et al.
Published: (2017)
by: Sykes, David A., et al.
Published: (2017)
Biased allosteric modulators at the metabotropic glutamate receptor 5
by: Sengmany, Kathy
Published: (2018)
by: Sengmany, Kathy
Published: (2018)
Biased allosteric modulators of metabotropic glutamate receptor 5
by: Sengmany, Kathy
Published: (2018)
by: Sengmany, Kathy
Published: (2018)
Dopamine D1 receptor involvement in latent inhibition and overshadowing
by: Nelson, Andrew J.D., et al.
Published: (2012)
by: Nelson, Andrew J.D., et al.
Published: (2012)
Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing
by: Nelson, Andrew J.D., et al.
Published: (2012)
by: Nelson, Andrew J.D., et al.
Published: (2012)
On-Demand Dopamine Receptor Activation via Photoresponsive Nanoparticle-Dopamine Conjugates with an Emphasis on Parkinson’s Disease
by: Alghamdi, Hajar
Published: (2024)
by: Alghamdi, Hajar
Published: (2024)
Structure activity relationships of novel and selective beta1-adrenoreceptor ligands
by: Mistry, Shailesh N.
Published: (2009)
by: Mistry, Shailesh N.
Published: (2009)
Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia
by: Lawford, B., et al.
Published: (2016)
by: Lawford, B., et al.
Published: (2016)
Investigations into β2-adrenoceptor pharmacology: kinetic analysis, mechanotransduction and allosteric modulation
by: Cullum, Sean A.
Published: (2024)
by: Cullum, Sean A.
Published: (2024)
A new fragment of Euripides' Ino
by: Finglass, P.J.
Published: (2014)
by: Finglass, P.J.
Published: (2014)
Allosteric interactions at adenosine A1 and A3 receptors: new insights into the role of small molecules and receptor dimerization
by: Hill, Stephen J., et al.
Published: (2014)
by: Hill, Stephen J., et al.
Published: (2014)
The fragments of the Roman historians: conventions and opportunities
by: Malloch, S.J.V.
Published: (2014)
by: Malloch, S.J.V.
Published: (2014)
Recent advances in electrochemical and optical sensing of dopamine
by: Eddin, Faten Bashar Kamal, et al.
Published: (2020)
by: Eddin, Faten Bashar Kamal, et al.
Published: (2020)
The dopamine D3-preferring D2/D3 dopamine receptor partial agonist, cariprazine, reverses behavioral changes in a rat neurodevelopmental model for schizophrenia
by: Watson, David J.G., et al.
Published: (2016)
by: Watson, David J.G., et al.
Published: (2016)
Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor
by: Isogai, Shin, et al.
Published: (2016)
by: Isogai, Shin, et al.
Published: (2016)
How Do Fatty Acids Cause Allosteric Binding of Drugs to Human Serum Albumin?
by: Chuang, Victor, et al.
Published: (2002)
by: Chuang, Victor, et al.
Published: (2002)
Effects of dopamine D1 modulation of the anterior cingulate cortex in a fear conditioning procedure
by: Pezze, Marie A., et al.
Published: (2015)
by: Pezze, Marie A., et al.
Published: (2015)
Universal Scherrer equation for graphene fragments
by: Lim, D.J., et al.
Published: (2020)
by: Lim, D.J., et al.
Published: (2020)
Reduced dopamine function within the medial shell of the nucleus accumbens enhances latent inhibition
by: Nelson, Andrew J.D., et al.
Published: (2011)
by: Nelson, Andrew J.D., et al.
Published: (2011)
Dissociable roles of dopamine within the core and medial shell of the nucleus accumbens in memory for objects and place
by: Nelson, Andrew J.D., et al.
Published: (2010)
by: Nelson, Andrew J.D., et al.
Published: (2010)
Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism
by: Corriden, Ross, et al.
Published: (2014)
by: Corriden, Ross, et al.
Published: (2014)
An inhibited dopamine synthesizing cell model of AADC deficiency
by: Khalid, Melati, et al.
Published: (2019)
by: Khalid, Melati, et al.
Published: (2019)
Metallogenesis of the Paleoproterozoic Piaba orogenic gold deposit, São Luís cratonic fragment, Brazil
by: Klein, E.L., et al.
Published: (2014)
by: Klein, E.L., et al.
Published: (2014)
Hyperactive mariner transposons are created by mutations that disrupt allosterism and increase the rate of transposon end synapsis
by: Liu, Danxu, et al.
Published: (2014)
by: Liu, Danxu, et al.
Published: (2014)
Design, Synthesis, and Development of Novel Intracellular Allosteric Modulators of CXC Chemokine Receptor 1 and 2
by: Francis, Rhys
Published: (2024)
by: Francis, Rhys
Published: (2024)
Universal sensors for identifying use-dependent intracellular allosteric modulators of G protein coupled receptors
by: Farmer, James
Published: (2024)
by: Farmer, James
Published: (2024)
Design, Synthesis, and Development of Novel Fluorescently Labelled Allosteric Probes for the Human Beta2-Adrenoceptor
by: Tuzer, Cemre
Published: (2023)
by: Tuzer, Cemre
Published: (2023)
Simultaneous determination of dopamine, ascorbic acid and uric acid with electrospun carbon nanofibers modified electrode
by: Liu, Yang, et al.
Published: (2008)
by: Liu, Yang, et al.
Published: (2008)
Similar Items
-
Structure–activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptor
by: Shonberg, Jeremy, et al.
Published: (2015) -
Novel fused arylpyrimidinone based allosteric modulators of the M1 muscarinic acetylcholine receptor
by: Mistry, Shailesh N., et al.
Published: (2016) -
A thieno[2,3-d]pyrimidine scaffold is a novel negative allosteric modulator of the dopamine D2 receptor
by: Fyfe, Tim J., et al.
Published: (2018) -
Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor
by: Mistry, Shailesh N., et al.
Published: (2013) -
4-Phenylpyridin-2-one derivatives: a novel class of positive allosteric modulator of the M1 muscarinic acetylcholine receptor
by: Mistry, Shailesh N., et al.
Published: (2015)